120 related articles for article (PubMed ID: 5191771)
1. [Our first experiences with the new hypotensive drug Catapresan].
Grujić M; Robović Z; Perinović M; Rizvanbegović B; Sarić V; Vasiljević M
Med Arh; 1968; 22(3):75-80. PubMed ID: 5191771
[No Abstract] [Full Text] [Related]
2. [Catapresan--a new hypotensive agent].
Tarkowska A
Pol Tyg Lek; 1969 Jun; 24(24):934-6. PubMed ID: 4896410
[No Abstract] [Full Text] [Related]
3. [Clinical experiences with the new antihypertensive agent Catapresan].
Messerich J
Med Klin; 1966 Dec; 61(52):2078-9. PubMed ID: 5999213
[No Abstract] [Full Text] [Related]
4. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
Bergström J; Bergquist-Poppen M; Bucht H
Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
[No Abstract] [Full Text] [Related]
5. [Evaluation of the anti-hypertensive effectiveness of Catapresan (ST-155)].
Ambrosioni E; Corbara F; Perri G
G Clin Med; 1971 Mar; 52(3):247-65. PubMed ID: 5121120
[No Abstract] [Full Text] [Related]
6. [Clinical studies on the antihypertensive effect of Catapresan].
Kreuziger H; Brehm H
Med Welt; 1968 Apr; 14():905-7. PubMed ID: 5718198
[No Abstract] [Full Text] [Related]
7. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
Fritsch H; Bachmann GW; Lenhard J
Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
[No Abstract] [Full Text] [Related]
8. [Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
Langer-Costanzi M
Clin Ter; 1970 Dec; 55(5):419-31. PubMed ID: 5516107
[No Abstract] [Full Text] [Related]
9. [Clinical experiences with a new antihypertensive agent].
Lieb W; Ridders K
Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
[No Abstract] [Full Text] [Related]
10. [Clinico-experimental study of a hypotensive drug: 2(2,6-dichloro-phenylamino)-2-imidazoline hydrochloride].
Caparello O; Contino A; Viola A; Pirro G
Clin Ter; 1971 Jul; 57(6):553-62. PubMed ID: 5136489
[No Abstract] [Full Text] [Related]
11. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
Palagi L; D'Elia M; Lanzara P; Criscione SM
Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
[No Abstract] [Full Text] [Related]
12. [Preliminary clinical experiences on the antihypertensive effect of 2-(2-6 diclorophenylamino)-imidazoline].
Corsini G; Di Filippo A; Cioffi A
Rass Int Clin Ter; 1971 Feb; 51(4):237-46. PubMed ID: 5576946
[No Abstract] [Full Text] [Related]
13. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
Borrello G
Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
[No Abstract] [Full Text] [Related]
14. [Clinical experience with Catapresan].
Laux L; Angelmann W
Med Monatsschr; 1967 Apr; 21(4):186-7. PubMed ID: 5584446
[No Abstract] [Full Text] [Related]
15. [Experience with Catapresan in the therapy of hypertension].
Michel D
Dtsch Med Wochenschr; 1968 Jul; 93(28):1375. PubMed ID: 5657231
[No Abstract] [Full Text] [Related]
16. Clonidine (Catapres): a new antihypertensive agent.
Khan A; Camel G; Perry HM
Curr Ther Res Clin Exp; 1970 Jan; 12(1):10-8. PubMed ID: 4984047
[No Abstract] [Full Text] [Related]
17. Tiamenidine, a centrally acting antihypertensive drug in essential hypertension [proceedings].
Zamboulis C; Hossmann V; Dollery CT; Eckert H
Br J Clin Pharmacol; 1979 Oct; 8(4):390P. PubMed ID: 508528
[No Abstract] [Full Text] [Related]
18. [Long-term clinical study and serial determination of urinary catecholamines using the new antihypertensive agent ST-155].
Villalpando J; Skromme D; Chávez B; Serrano P
Arch Inst Cardiol Mex; 1968; 38(6):841-50. PubMed ID: 5711376
[No Abstract] [Full Text] [Related]
19. [Clinical experimentation with a new imidazoline derivative (ST155) in the treatment of arterial hypertension].
Ferreira EB; Eichemberg R; Berlitz MF
Hospital (Rio J); 1969 Jun; 75(6):2139-51. PubMed ID: 5311472
[No Abstract] [Full Text] [Related]
20. [Clinical studies on the mechanism of action of 2-(2,6-dichlorphenylamino)-2-imidazolinehydrochloric acid (Catapresan)].
Scheja HW; Strum A
Verh Dtsch Ges Inn Med; 1968; 74():559-62. PubMed ID: 5714381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
